Clinical Trial Update: Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the FOLFIRI plus cetuximab regimen for Stage IV colorectal cancer patients with FcGammaRIIIa V/V, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Colorectal Cancer, ADCC | Phase 2 | Status: RECRUITING